Axsome Therapeutics, Inc. short interest in 2019
In 2019, Axsome Therapeutics, Inc.'s disclosed short interest ran from 6.05% of shares outstanding on 15 Jan 2019 to 14.58% on 31 Dec 2019, a change of +8.53 percentage points. The year's high was 18.71% on 15 Jul 2019 and its low 6.05% on 15 Jan 2019, averaging 15.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.81 days on 30 Aug 2019. Full history: Axsome Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 6.05% (15 Jan 2019)
- End of year
- 14.58% (31 Dec 2019)
- Change
- +8.53 pp
- High
- 18.71% (15 Jul 2019)
- Low
- 6.05% (15 Jan 2019)
- Average
- 15.18%
- Highest days to cover
- 12.81 (30 Aug 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 6.05% | 1.00 | |
| 31 Jan 2019 | 6.93% | 2.26 | |
| 15 Feb 2019 | 9.65% | 2.90 | |
| 28 Feb 2019 | 9.74% | 4.85 | |
| 15 Mar 2019 | 11.54% | 3.87 | results (8-K), 10-K filed |
| 29 Mar 2019 | 15.31% | 2.15 | |
| 15 Apr 2019 | 15.84% | 5.57 | |
| 30 Apr 2019 | 15.10% | 4.09 | |
| 15 May 2019 | 17.07% | 4.11 | 10-Q filed, results (8-K) |
| 31 May 2019 | 18.56% | 4.25 | |
| 14 Jun 2019 | 17.23% | 5.47 | |
| 28 Jun 2019 | 17.70% | 3.69 | |
| 15 Jul 2019 | 18.71% | 6.58 | |
| 31 Jul 2019 | 17.77% | 7.38 | |
| 15 Aug 2019 | 17.59% | 7.78 | 10-Q filed, results (8-K) |
| 30 Aug 2019 | 17.20% | 12.81 | |
| 13 Sep 2019 | 16.29% | 11.05 | |
| 30 Sep 2019 | 16.24% | 6.87 | |
| 15 Oct 2019 | 17.74% | 3.66 | |
| 31 Oct 2019 | 17.07% | 7.08 | |
| 15 Nov 2019 | 17.28% | 7.72 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 17.66% | 5.06 | |
| 13 Dec 2019 | 15.51% | 4.10 | |
| 31 Dec 2019 | 14.58% | 1.84 |
See also: Axsome Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.